{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,14]],"date-time":"2025-10-14T14:36:27Z","timestamp":1760452587101},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2014,3,31]],"date-time":"2014-03-31T00:00:00Z","timestamp":1396224000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Pharmacol Toxicol"],"published-print":{"date-parts":[[2014,12]]},"DOI":"10.1186\/2050-6511-15-20","type":"journal-article","created":{"date-parts":[[2014,3,31]],"date-time":"2014-03-31T23:02:07Z","timestamp":1396306927000},"update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Antihypertensive drug treatment changes in the general population: the colaus study"],"prefix":"10.1186","volume":"15","author":[{"given":"Vanessa","family":"Christe","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G\u00e9rard","family":"Waeber","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter","family":"Vollenweider","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pedro","family":"Marques-vidal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2014,3,31]]},"reference":[{"issue":"1","key":"301_CR1","doi-asserted-by":"publisher","first-page":"72","DOI":"10.3122\/jabfm.2007.01.060094","volume":"20","author":"WJ Elliott","year":"2007","unstructured":"Elliott WJ, Plauschinat CA, Skrepnek GH, Gause D: Persistence, adherence, and risk of discontinuation associated with commonly prescribed antihypertensive drug monotherapies. J Am Board Fam Med. 2007, 20 (1): 72-80.","journal-title":"J Am Board Fam Med"},{"issue":"1","key":"301_CR2","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1097\/HJR.0b013e32831e9511","volume":"16","author":"N Danon-Hersch","year":"2009","unstructured":"Danon-Hersch N, Marques-Vidal P, Bovet P, Chiolero A, Paccaud F, Pecoud A, Hayoz D, Mooser V, Waeber G, Vollenweider P: Prevalence, awareness, treatment and control of high blood pressure in a Swiss city general population: the CoLaus study. Eur J Cardiovasc Prev Rehabil. 2009, 16 (1): 66-72.","journal-title":"Eur J Cardiovasc Prev Rehabil"},{"key":"301_CR3","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1186\/1475-2840-8-18","volume":"8","author":"P Bramlage","year":"2009","unstructured":"Bramlage P, Hasford J: Blood pressure reduction, persistence and costs in the evaluation of antihypertensive drug treatment\u2013a review. Cardiovasc Diabetol. 2009, 8: 18-","journal-title":"Cardiovasc Diabetol"},{"key":"301_CR4","first-page":"w13169","volume":"141","author":"R Brenner","year":"2011","unstructured":"Brenner R, Waeber B, Allemann Y: Medical treatment of hypertension in Switzerland. The 2009 Swiss Hypertension Survey (SWISSHYPE). Swiss Med Wkly. 2011, 141: w13169-","journal-title":"Swiss Med Wkly"},{"issue":"9","key":"301_CR5","doi-asserted-by":"publisher","first-page":"2597","DOI":"10.1185\/03007990802319364","volume":"24","author":"DI Brixner","year":"2008","unstructured":"Brixner DI, Jackson KC, Sheng X, Nelson RE, Keskinaslan A: Assessment of adherence, persistence, and costs among valsartan and hydrochlorothiazide retrospective cohorts in free-and fixed-dose combinations. Curr Med Res Opin. 2008, 24 (9): 2597-2607.","journal-title":"Curr Med Res Opin"},{"issue":"8","key":"301_CR6","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1038\/sj.jhh.1001873","volume":"19","author":"C Bourgault","year":"2005","unstructured":"Bourgault C, Senecal M, Brisson M, Marentette MA, Gregoire JP: Persistence and discontinuation patterns of antihypertensive therapy among newly treated patients: a population-based study. J Hum Hypertens. 2005, 19 (8): 607-613.","journal-title":"J Hum Hypertens"},{"issue":"11","key":"301_CR7","doi-asserted-by":"publisher","first-page":"2093","DOI":"10.1097\/01.hjh.0000186832.41125.8a","volume":"23","author":"G Mazzaglia","year":"2005","unstructured":"Mazzaglia G, Mantovani LG, Sturkenboom MC, Filippi A, Trifiro G, Cricelli C, Brignoli O, Caputi AP: Patterns of persistence with antihypertensive medications in newly diagnosed hypertensive patients in Italy: a retrospective cohort study in primary care. J Hypertens. 2005, 23 (11): 2093-2100.","journal-title":"J Hypertens"},{"key":"301_CR8","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1186\/1471-2261-8-6","volume":"8","author":"M Firmann","year":"2008","unstructured":"Firmann M, Mayor V, Vidal PM, Bochud M, Pecoud A, Hayoz D, Paccaud F, Preisig M, Song KS, Yuan X, Danoff TM, Stirnadel HA, Waterworth D, Mooser V, Waeber G, Vollenweider P: The CoLaus study: a population-based study to investigate the epidemiology and genetic determinants of cardiovascular risk factors and metabolic syndrome. BMC Cardiovasc Disord. 2008, 8: 6-","journal-title":"BMC Cardiovasc Disord"},{"issue":"6998","key":"301_CR9","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1136\/bmj.311.6998.158","volume":"311","author":"ME Lean","year":"1995","unstructured":"Lean ME, Han TS, Morrison CE: Waist circumference as a measure for indicating need for weight management. BMJ. 1995, 311 (6998): 158-161.","journal-title":"BMJ"},{"key":"301_CR10","unstructured":"Anatomical Therapeutic Chemical (ATC) classification system.http:\/\/www.whocc.no\/atc\/structure_and_principles\/,"},{"key":"301_CR11","unstructured":"2009 Swiss Society of Hypertension Guidelines.http:\/\/swisshypertension.ch\/guidelines.htm,"},{"key":"301_CR12","unstructured":"Hypertension: Clinical Management of Primary Hypertension in Adults.http:\/\/publications.nice.org.uk\/hypertension-cg127\/guidance#choosing-antihypertensive-drug-treatment-2,"},{"issue":"28","key":"301_CR13","doi-asserted-by":"publisher","first-page":"2159","DOI":"10.1093\/eurheartj\/eht151","volume":"34","author":"G Mancia","year":"2013","unstructured":"Mancia G, Fagard R, Narkiewicz K, Redon J, Zanchetti A, B\u00f6hm M, Christiaens T, Cifkova R, De Backer G, Dominiczak A, Galderisi M, Grobbee DE, Jaarsma T, Kirchhof P, Kjeldsen SE, Laurent S, Manolis AJ, Nilsson PM, Ruilope LM, Schmieder RE, Sirnes PA, Sleight P, Viigimaa M, Waeber B, Zannad F, Dominiczak A, Narkeiwicz K, Nilsson PM, Burnier M, Viigimaa M: 2013 ESH\/ESC guidelines for the management of arterial hypertension: the task force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). Eur Heart J. 2013, 34 (28): 2159-219. doi: 10.1093\/eurheartj\/eht151. Epub 2013 Jun 14","journal-title":"Eur Heart J"},{"issue":"8","key":"301_CR14","doi-asserted-by":"publisher","first-page":"1347","DOI":"10.1016\/S0149-2918(02)80039-X","volume":"24","author":"L Degli Esposti","year":"2002","unstructured":"Degli Esposti L, Degli Esposti E, Valpiani G, Di Martino M, Saragoni S, Buda S, Baio G, Capone A, Sturani A: A retrospective, population-based analysis of persistence with antihypertensive drug therapy in primary care practice in Italy. Clin Ther. 2002, 24 (8): 1347-1357. discussion 1346","journal-title":"Clin Ther"},{"issue":"6","key":"301_CR15","first-page":"999","volume":"3","author":"M Veronesi","year":"2007","unstructured":"Veronesi M, Cicero AF, Prandin MG, Dormi A, Cosentino E, Strocchi E, Borghi C: A prospective evaluation of persistence on antihypertensive treatment with different antihypertensive drugs in clinical practice. Vasc Health Risk Manag. 2007, 3 (6): 999-1005.","journal-title":"Vasc Health Risk Manag"},{"issue":"4","key":"301_CR16","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1016\/S0828-282X(08)70175-2","volume":"24","author":"J Lachaine","year":"2008","unstructured":"Lachaine J, Petrella RJ, Merikle E, Ali F: Choices, persistence and adherence to antihypertensive agents: evidence from RAMQ data. Can J Cardiol. 2008, 24 (4): 269-273.","journal-title":"Can J Cardiol"},{"issue":"2","key":"301_CR17","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1023\/A:1007735311894","volume":"12","author":"WH Aellig","year":"1998","unstructured":"Aellig WH: Adverse reactions to antihypertensive therapy. Cardiovasc Drugs Ther. 1998, 12 (2): 189-196.","journal-title":"Cardiovasc Drugs Ther"},{"issue":"5","key":"301_CR18","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1016\/S0149-2918(01)80021-7","volume":"23","author":"JP Gregoire","year":"2001","unstructured":"Gregoire JP, Moisan J, Guibert R, Ciampi A, Milot A, Cote I, Gaudet M: Tolerability of antihypertensive drugs in a community-based setting. Clin Ther. 2001, 23 (5): 715-726.","journal-title":"Clin Ther"},{"issue":"10","key":"301_CR19","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1038\/sj.jhh.1001899","volume":"19","author":"K Chen","year":"2005","unstructured":"Chen K, Chiou CF, Plauschinat CA, Frech F, Harper A, Dubois R: Patient satisfaction with antihypertensive therapy. J Hum Hypertens. 2005, 19 (10): 793-799.","journal-title":"J Hum Hypertens"},{"issue":"20","key":"301_CR20","doi-asserted-by":"publisher","first-page":"2499","DOI":"10.1093\/eurheartj\/ehr177","volume":"32","author":"PS Sever","year":"2011","unstructured":"Sever PS, Messerli FH: Hypertension management 2011: optimal combination therapy. Eur Heart J. 2011, 32 (20): 2499-2506.","journal-title":"Eur Heart J"},{"issue":"2","key":"301_CR21","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1016\/j.amjmed.2009.08.008","volume":"123","author":"O Friedman","year":"2010","unstructured":"Friedman O, McAlister FA, Yun L, Campbell NR, Tu K, Canadian Hypertension Education Program Outcomes Research T: Antihypertensive drug persistence and compliance among newly treated elderly hypertensives in ontario. Am J Med. 2010, 123 (2): 173-181.","journal-title":"Am J Med"},{"issue":"2","key":"301_CR22","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1038\/ajh.2007.33","volume":"21","author":"LE Bautista","year":"2008","unstructured":"Bautista LE: Predictors of persistence with antihypertensive therapy: results from the NHANES. Am J Hypertens. 2008, 21 (2): 183-188.","journal-title":"Am J Hypertens"},{"issue":"11","key":"301_CR23","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1002\/pds.1156","volume":"14","author":"JA Erkens","year":"2005","unstructured":"Erkens JA, Panneman MM, Klungel OH, van den Boom G, Prescott MF, Herings RM: Differences in antihypertensive drug persistence associated with drug class and gender: a PHARMO study. Pharmacoepidemiol Drug Saf. 2005, 14 (11): 795-803.","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"17","key":"301_CR24","doi-asserted-by":"publisher","first-page":"1842","DOI":"10.1001\/archinte.166.17.1842","volume":"166","author":"PM Ho","year":"2006","unstructured":"Ho PM, Spertus JA, Masoudi FA, Reid KJ, Peterson ED, Magid DJ, Krumholz HM, Rumsfeld JS: Impact of medication therapy discontinuation on mortality after myocardial infarction. Arch Intern Med. 2006, 166 (17): 1842-1847.","journal-title":"Arch Intern Med"},{"issue":"5","key":"301_CR25","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1038\/ajh.2011.261","volume":"25","author":"G Corrao","year":"2012","unstructured":"Corrao G, Zambon A, Parodi A, Merlino L, Mancia G: Incidence of cardiovascular events in Italian patients with early discontinuations of antihypertensive, lipid-lowering, and antidiabetic treatments. Am J Hypertens. 2012, 25 (5): 549-555.","journal-title":"Am J Hypertens"},{"issue":"10","key":"301_CR26","doi-asserted-by":"publisher","first-page":"706","DOI":"10.1111\/j.1524-6175.2006.05615.x","volume":"8","author":"R Weiss","year":"2006","unstructured":"Weiss R, Buckley K, Clifford T: Changing patterns of initial drug therapy for the treatment of hypertension in a Medicaid population, 2001\u20132005. J Clin Hypertens (Greenwich). 2006, 8 (10): 706-712.","journal-title":"J Clin Hypertens (Greenwich)"},{"issue":"10","key":"301_CR27","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1038\/jhh.2009.109","volume":"24","author":"MC Wong","year":"2010","unstructured":"Wong MC, Jiang JY, Griffiths SM: Switching of antihypertensive drugs among 93,286 Chinese patients: a cohort study. J Hum Hypertens. 2010, 24 (10): 669-677.","journal-title":"J Hum Hypertens"},{"key":"301_CR28","volume-title":"WHO MONICA","author":"KK Wolf HK","year":"1998","unstructured":"Wolf HK KK, Tolonen H, Ruokokoski E: Participation Rates, Quality of Sampling Frames and Sampling Fractions in the MONICA Surveys. WHO MONICA. 1998, Available at http:\/\/www.thl.fi\/publications\/monica\/nonres\/nonres.htm assessed May 2013"},{"issue":"10","key":"301_CR29","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1038\/jhh.2010.2","volume":"24","author":"NM Engel-Nitz","year":"2010","unstructured":"Engel-Nitz NM, Darkow T, Lau H: Antihypertensive medication changes and blood pressure goal achievement in a managed care population. J Hum Hypertens. 2010, 24 (10): 659-668.","journal-title":"J Hum Hypertens"}],"container-title":["BMC Pharmacology and Toxicology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/2050-6511-15-20.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/2050-6511-15-20\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/2050-6511-15-20","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/2050-6511-15-20.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,2]],"date-time":"2021-09-02T03:14:19Z","timestamp":1630552459000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpharmacoltoxicol.biomedcentral.com\/articles\/10.1186\/2050-6511-15-20"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,3,31]]},"references-count":29,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014,12]]}},"alternative-id":["301"],"URL":"https:\/\/doi.org\/10.1186\/2050-6511-15-20","relation":{},"ISSN":["2050-6511"],"issn-type":[{"value":"2050-6511","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,3,31]]},"assertion":[{"value":"23 September 2013","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 March 2014","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 March 2014","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"20"}}